Cetuximab Attenuates Metastasis and U-Par Expression in Non-Small Cell Lung Cancer: U-Par and E-Cadherin Are Novel Biomarkers of Cetuximab Sensitivity

Cancer Research - United States
doi 10.1158/0008-5472.can-08-3236
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Cetuximab and Biomarkers in Non-Small-Cell Lung Carcinoma

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2012English

Immuno-Pet Imaging for Non-Invasive Assessment of Cetuximab Accumulation in Non-Small Cell Lung Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Association of EGFR Expression Level and Cetuximab Activity in Patient-Derived Xenograft Models of Human Non-Small Cell Lung Cancer

Clinical Cancer Research
Cancer ResearchOncology
2014English

A Review of Clinical Trials of Cetuximab Combined With Radiotherapy for Non-Small Cell Lung Cancer

Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2012English

EGFR Expression and Survival in Patients Given Cetuximab and Chemoradiation for Stage III Non-Small Cell Lung Cancer: A Secondary Analysis of RTOG 0324

Radiotherapy and Oncology
Nuclear MedicineOncologyRadiologyHematologyImaging
2014English

Neural-Cadherin Expression Associated With Angiogenesis in Non-Small-Cell Lung Cancer Patients

British Journal of Cancer
Cancer ResearchOncology
2003English

Targeting Angiogenesis in Advanced Non-Small-Cell Lung Cancer: Are Biomarkers Needed?

Current Respiratory Care Reports
2013English

Potential Importance of Protease Activated Receptor (PAR)-1 Expression in the Tumor Stroma of Non-Small-Cell Lung Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2017English

Circulating Microparticles Are Prognostic Biomarkers in Advanced Non-Small Cell Lung Cancer Patients

Oncotarget
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy